• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

[NATURE] Neonatal RSV infection associated with increased susceptibility to allergic asthma

bys25qthea
September 11, 2012
in Pediatrics, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: CC/CDC. EM micrograph of RSV

Primer:  Previous studies have demonstrated a strong association between recurrent Respiratory Syncytial Virus (RSV) infections in neonates and the development of asthma later in life. In some populations, as high as 40-50% of those infected with RSV go on to eventually develop asthmatic symptoms. Unfortunately, little is currently known about the specific pathologic processes underlying this association.    

This [experimental] study: Published on Sept. 9th in Nature Medicine used a murine model to compare T-regulatory (T-reg) cell function in infants with multiple early RSV infections to infection-free controls. The study evaluated the effects of RSV on the development of maternally transferred immune tolerance in mice pups using the model antigen ovalbumin (OVA). In the study, mice pups were exposed to OVA containing breast milk and then infected with RSV at weeks 3, 4, and 5 after weaning in order to mimic recurrent infections in humans. Upon subsequent challenge with aerosol OVA on week 7, the RSV infected mice failed to develop tolerance, resulting in an allergic response to OVA. Uninfected pups developed normal tolerance and did not mount an allergic response. Allergic responses in RSV infected pups were associated with IL-4 receptor α (IL-4Rα) dependent T-reg cell dysfunction whereby T-reg cells lost their suppressive ability and developed a T helper cell type 2 (Th-2) phenotype. The abnormal T-reg cells were shown to promote increased airway cellular infiltration and mucus production via increased production of the Th-2 specific inflammatory cytokines IL-5 and IL-13, leading to increased central airway resistance and subsequent asthmatic response upon antigenic stimulation.

In sum: Recurrent RSV infection in neonatal mice is associated with impaired immune tolerance and the development of allergic asthma. RSV infection appears to alter T-reg cell function promoting a Th-2 like phenotype in T-reg cells resulting in airway hypersensitivity and asthma induction.  If confirmed by independent human trials, the results could signal a greater role for neonatal viral infections in the pathogenesis of asthma and other immunologic hypersensitivity disorders. In addition, treatment and preventive strategies aimed at inhibiting RSV mediated T-reg to Th-2 conversion may help to reduce the incidence and severity of asthma in children. More clinical research is needed in this area. Major limitations of the study included the presence of species-specific differences in immune function and regulation between mice and humans and the possibility of pathogenic confounds.

Click to read in Nature Medicine

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please aee a healthcare professional if you seek medical advice.

RELATED REPORTS

Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab

2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Previous Post

[Ann Emerg Med.] Topical antibiotics help prevent infection in minor wounds

Next Post

[Neurology] Heavy alcohol intake and intracerebral hemorrhage: Characteristics and effect on outcome

RelatedReports

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab

September 3, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]

September 3, 2025
Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial
Hematology

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

September 2, 2025
Cardiology

An absence of cardiovascular risk factors is linked to over ten additional healthy years

September 2, 2025
Next Post

[Neurology] Heavy alcohol intake and intracerebral hemorrhage: Characteristics and effect on outcome

[CIRCULATION] NSAID use after heart attacks associated with increased coronary risk, death

[Ann Intern Med.] Asymptomatic, low risk women should not be screened for ovarian cancer – new USPSTF statement

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab
  • 2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
  • Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.